Drug intelligence / Profile preview

casiopeina IIgly

Development stage
Preclinical
Lead developer
Universidad Nacional Autónoma de México
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Intravenous
01

Overview

**Casiopeina IIgly** is a mixed chelate **copper(II) coordination compound** in the Casiopeínas family, developed as a novel antineoplastic agent. Its mechanism of action includes the generation of **reactive oxygen species (ROS)** via redox cycling with glutathione (GSH), causing **oxidative stress**, rapid depletion of cellular GSH, mitochondrial dysfunction, membrane depolarization, and mitochondrial DNA damage. These activities collectively lead to metabolic disruption and **cell death** in several cancer cell lines, including lung, breast, and cervical cancer cells[1][2][3][5]. It also interacts with DNA and induces apoptosis and autophagy in tumor cells, while showing selectivity for malignant over normal cells[2][5].

Brand names
Casiopeína IIgly
Other names
Cu(4,7-dimethyl-1,10-phenanthroline)(glycinate)]NO3CasIIgly
02

Targets

DNA

Beyond the preview

Go deeper on casiopeina IIgly.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on casiopeina IIgly.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call